CANTON, Mass. (AP) _ Organogenesis Holdings Inc. (ORGO) on Tuesday reported a loss of $10.7 million in its third quarter.
On a per-share basis, the Canton, Massachusetts-based company said it had a loss of 12 cents.
The regenerative medicine company posted revenue of $64.3 million in the period.
Organogenesis expects full-year revenue in the range of $253 million to $260 million.